We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
551
People Inc
PPLI
$3.13B
| $248K | 0.03% |
5,768
-15,594
| -73% | -$611K |
|
552
Restaurant Brands International
QSR
$25.3B
| $247K | 0.03% |
3,166
-24,016
| -88% | -$1.67M |
|
553
Patterson-UTI
PTEN
$3.9B
| $247K | 0.03% |
+22,899
| New | +$278K |
|
554
Flowers Foods
FLO
$1.53B
| $244K | 0.03% |
10,854
-15,006
| -58% | -$324K |
|
555
Shutterstock
SSTK
$223M
| $244K | 0.03% |
+5,058
| New | +$213K |
|
556
Sumitomo Mitsui Financial
SMFG
$160B
| $244K | 0.03% |
+25,161
| New | +$244K |
|
557
Qorvo
QRVO
$7.89B
| $242K | 0.03% |
+2,153
| New | +$208K |
|
558
Fortive
FTV
$18B
| $242K | 0.03% |
+4,355
| New | +$230K |
|
559
Organon & Co
OGN
$3.56B
| $242K | 0.03% |
16,752
+6,696
| +67% | +$91.1K |
|
560
Waste Management
WM
$90.5B
| $239K | 0.03% |
1,332
-5,928
| -82% | -$994K |
|
561
Hancock Whitney
HWC
$6.26B
| $230K | 0.03% |
+4,737
| New | +$189K |
|
562
TD Synnex
SNX
$20.3B
| $230K | 0.03% |
+2,137
| New | +$210K |
|
563
Cinemark Holdings
CNK
$4.39B
| $225K | 0.03% |
15,960
-40,100
| -72% | -$624K |
|
564
Smith & Nephew
SNN
$13.5B
| $224K | 0.03% |
+8,213
| New | +$204K |
|
565
ACM Research
ACMR
$5.43B
| $223K | 0.03% |
11,436
-27,503
| -71% | -$481K |
|
566
H.B. Fuller
FUL
$3.07B
| $223K | 0.03% |
+2,740
| New | +$202K |
|
567
Bloomin' Brands
BLMN
$774M
| $221K | 0.03% |
+7,862
| New | +$191K |
|
|
EFOR
568
Everforth Inc
EFOR
$1.22B
| $221K | 0.03% |
2,298
-5,486
| -70% | -$479K |
|
569
Consolidated Edison
ED
$39.8B
| $221K | 0.03% |
+2,427
| New | +$217K |
|
|
HOLX
570
DELISTED
Hologic
HOLX
| $220K | 0.03% |
3,081
-49,229
| -94% | -$3.43M |
|
571
CSX Corp
CSX
$92.3B
| $219K | 0.03% |
6,308
-37,522
| -86% | -$1.2M |
|
572
Carnival Corporation Ltd
CCL
$39.4B
| $217K | 0.03% |
+11,720
| New | +$170K |
|
573
HSBC
HSBC
$370B
| $215K | 0.02% |
5,314
-28,917
| -84% | -$1.12M |
|
574
KLA
KLAC
$239B
| $212K | 0.02% |
3,650
-6,900
| -65% | -$359K |
|
575
CrowdStrike
CRWD
$206B
| $211K | 0.02% |
3,304
-38,864
| -92% | -$2.03M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.